|
TFE3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.937600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.886000E-02 |
| Normal-vs-Stage2 |
4.467000E-01 |
| Normal-vs-Stage3 |
5.624400E-02 |
| Normal-vs-Stage4 |
7.304000E-01 |
| Stage1-vs-Stage2 |
1.286020E-01 |
| Stage1-vs-Stage3 |
1.060360E-02 |
| Stage1-vs-Stage4 |
1.806570E-01 |
| Stage2-vs-Stage3 |
3.419400E-01 |
| Stage2-vs-Stage4 |
7.783600E-01 |
| Stage3-vs-Stage4 |
3.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.347200E-01 |
| Normal-vs-AfricanAmerican |
6.321400E-01 |
| Normal-vs-Asian |
6.690000E-01 |
| Caucasian-vs-AfricanAmerican |
4.506800E-01 |
| Caucasian-vs-Asian |
8.483000E-01 |
| AfricanAmerican-vs-Asian |
6.878200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.937600E-02 |
| Normal-vs-Female |
1.179600E-03 |
| Male-vs-Female |
6.47190000035991E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.062400E-01 |
| Normal-vs-Extreme_Weight |
5.619600E-02 |
| Normal-vs-Obese |
1.638380E-01 |
| Normal-vs-Extreme_Obese |
2.116000E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.876200E-02 |
| Normal_Weight-vs-Obese |
5.396400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.153800E-02 |
| Extreme_Weight-vs-Obese |
5.564800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.181200E-01 |
| Obese-vs-Extreme_Obese |
1.455100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.455770E-01 |
| Normal-vs-Age(41-60Yrs) |
2.935800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.758000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.931800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.389800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.660100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.440430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.261970E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.079000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.279200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.910300E-02 |
| Normal-VS-Type2 PRCC |
6.504000E-01 |
| Normal-VS-KIRP CIMP |
1.089700E-02 |
| Normal-VS-Unclassified PRCC |
5.495900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.286500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.235700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.302530E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.282090E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.667000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.558100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.136000E-01 |
| Normal-vs-N1 |
3.560000E-02 |
| Normal-vs-N2 |
8.940400E-02 |
| N0-vs-N1 |
2.134000E-02 |
| N0-vs-N2 |
1.838460E-04 |
| N1-vs-N2 |
3.807800E-01 |
|
|
